1-2 of 2
Kousei Kageyama, MD
Close
Sort by
Journal Articles

A Novel Reduced-Toxicity Myeloablative Conditioningusing Full-Dose Busulfan and Melphalan For Cord Blood Transplantation Provides Durable Engraftment and Remission Without Increasing Non-Relapse Mortality In Advanced Myeloid Malignancies

Hisashi Yamamoto, MD, Naoyuki Uchida, MD, PhD, Kousei Kageyama, MD, Daisuke Kaji, MD, Sachie Wada, MD, Aya Nishida, MD, Hikari Ota, MD, Kazuya Ishiwata, MD, Masanori Tsuji, MD, Shinsuke Takagi, MD, Go Yamamoto, MD, PhD, Yuki Asano-Mori, MD, PhD, Koji Izutsu, MD, PhD, Atsushi Wake, MD, PhD, Shuichi Taniguchi, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 2042.
https://doi.org/10.1182/blood.V122.21.2042.2042
Published: 2013
Journal Articles

Infliximab Versus Rabbit Anti-Thymocyte Globulin As a Salvage Treatment For Steroid-Refractory Acute Graft-Versus-Host Disease After Reduced-Intensity Cord Blood Transplantation In Adults

Kazuya Ishiwata, MD, Hisashi Yamamoto, MD, Kousei Kageyama, MD, Daisuke Kaji, MD, Sachie Wada, MD, Aya Nishida, MD, Hikari Ota, MD, Shinsuke Takagi, MD, Masanori Tsuji, MD, Go Yamamoto, MD, PhD, Yuki Asano-Mori, MD, PhD, Naoyuki Uchida, MD, PhD, Koji Izutsu, MD, PhD, Atsushi Wake, MD, PhD, Akiko Yoneyama, MD, PhD, Shigeyoshi Makino, MD, PhD, Shuichi Taniguchi, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 4592.
https://doi.org/10.1182/blood.V122.21.4592.4592
Published: 2013